| Quantitatively characterizing drug‐induced arrhythmic contractile motions of human stem cell‐derived cardiomyocytes P Hoang, N Huebsch, SH Bang, BA Siemons, BR Conklin, KE Healy, ... Biotechnology and bioengineering 115 (8), 1958-1970, 2018 | 8 | 2018 |
| Efficacy of HER2-targeted intraperitoneal 225Ac α-pretargeted radioimmunotherapy for small-volume ovarian peritoneal carcinomatosis SK Chung, DB Vargas, CS Chandler, S Katugampola, DR Veach, ... Journal of Nuclear Medicine 64 (9), 1439-1445, 2023 | 5 | 2023 |
| Self-assembling and disassembling bispecific antibody platform for pretargeted radioimmunotherapy against GPA33 in a xenograft model of colorectal peritoneal carcinomatosis S Chung, M Wang, D Veach, S Cheal, DB Vargas, SH Seo, B Punzalan, ... Cancer Research 81 (13_Supplement), 1391-1391, 2021 | 1 | 2021 |
| Self-assembling and disassembling (SADA) domain is critical to the binding, and anti-tumor efficacy of GD2-SADA BH Santich, SL Kjellev, S Cheal, L Wang, M Gillberg, M Vadlamudi, ... Cancer Research 82 (12_Supplement), 3309-3309, 2022 | | 2022 |
| Establishment of efficacy of DOTA-based pretargeted radioimmunotherapy with a bivalent radiohapten for enhanced therapeutic indices B Vaughn, D Veach, DB Vargas, S Seo, B Punzalan, P Zanzonico, H Xu, ... Journal of Nuclear Medicine 63 (supplement 2), 2881-2881, 2022 | | 2022 |
| 111In/225Ac theranostic pretargeting of nodular colorectal peritoneal carcinomatosis: preclinical SPECT and autoradiography studies S Chung, C Chandler, D Veach, M McDevitt, P Zanzonico, S Seo, ... Nuclear Medicine and Biology 108, S50, 2022 | | 2022 |
| Synthesis and evaluation of a bivalent radiohapten for DOTA-based pretargeted radioimmunotherapy D Veach, B Vaughn, DB Vargas, S Seo, B Punzalan, H Xu, H Guo, ... Nuclear Medicine and Biology 108, S61-S62, 2022 | | 2022 |
| Abstract P168: Pretargeted radioimmunotherapy using 225Ac for intraperitoneal Her2-expressing epithelial ovarian carcinoma xenografts SK Chung, CS Chandler, DB Vargas, SH Seo, MR McDevitt, D Veach, ... Molecular Cancer Therapeutics 20 (12_Supplement), P168-P168, 2021 | | 2021 |
| Pretargeted radioimmunotherapy using Ac-225 for intraperitoneal Her2-expressing epithelial ovarian carcinoma xenografts SK Chung, CS Chandler, DB Vargas, SH Seo, MR McDevitt, D Veach, ... MOLECULAR CANCER THERAPEUTICS 20 (12), 2021 | | 2021 |
| Optimized pretargeting of [89Zr] Zr-DO3A-proteus radiohapten in rodent models of human colorectal cancer A Le Roux, S Cheal, D Veach, O Ouerfelli, G Yang, V Longo, H Guo, ... Nuclear Medicine and Biology 96, S3-S4, 2021 | | 2021 |
